DEREK J MAETZOLD
CIK 1239501 · Pres. & Chief Exec. Officer · last filed 2026-09-23
DEREK J MAETZOLD is a Pres. & Chief Exec. Officer who has filed 232 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for CSTL, was dated Sep 23, 2026. Across all open-market trades the lifetime net is −$96.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.22M
2
232
-$96.89M
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
Filer Profile
SUITE 201
FRIENDSWOOD, TX 77546
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CSTL | Pres. & Chief Exec. Officer | 62,414 | $35.49 | $2.22M | -$96.89M | 196 | 2026-09-23 |
| ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted | V.P., Marketing & Sales | 0 | — | — | $0 | 4 | 2008-04-03 |
Recent Filings
232 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-23 | CSTL | Mixed | −5,916 | -$491.7K | EDGAR |
| 2026-09-15 | CSTL | Mixed | −5,934 | -$444.4K | EDGAR |
| 2026-09-11 | CSTL | Notice (144) | −29,014 | -$938.0K | EDGAR |
| 2026-09-01 | CSTL | Mixed | −6,132 | -$586.4K | EDGAR |
| 2026-08-18 | CSTL | Mixed | −6,132 | -$214.5K | EDGAR |
| 2026-08-14 | CSTL | Notice (144) | −25,792 | -$764.0K | EDGAR |
| 2026-08-06 | CSTL | Mixed | −16,114 | -$1.16M | EDGAR |
| 2026-08-06 | CSTL | Mixed | −16,114 | -$1.16M | EDGAR |
| 2026-08-04 | CSTL | Mixed | −11,502 | -$826.5K | EDGAR |
| 2026-07-31 | CSTL | Notice (144) | −67,662 | -$1.89M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.